ING Groep NV boosted its position in shares of Viveve Medical, Inc. (NASDAQ:VIVE) by 93.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 325,000 shares of the company’s stock after acquiring an additional 157,200 shares during the period. ING Groep NV owned approximately 1.67% of Viveve Medical worth $1,703,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Rhumbline Advisers bought a new stake in shares of Viveve Medical in the 2nd quarter valued at approximately $110,000. JPMorgan Chase & Co. acquired a new position in shares of Viveve Medical in the 2nd quarter worth approximately $151,000. Virtu KCG Holdings LLC acquired a new position in shares of Viveve Medical in the 2nd quarter worth approximately $169,000. Schwab Charles Investment Management Inc. acquired a new position in shares of Viveve Medical in the 2nd quarter worth approximately $189,000. Finally, California State Teachers Retirement System acquired a new position in Viveve Medical during the 2nd quarter worth $190,000. Hedge funds and other institutional investors own 67.02% of the company’s stock.
A number of research analysts have recently weighed in on the company. ValuEngine downgraded Viveve Medical from a “sell” rating to a “strong sell” rating in a research note on Friday, December 1st. Mizuho initiated coverage on Viveve Medical in a research note on Thursday, November 16th. They issued a “buy” rating and a $10.00 price target on the stock. Finally, Cowen set a $11.00 price objective on shares of Viveve Medical and gave the company a “buy” rating in a research report on Monday, October 23rd. One equities research analyst has rated the stock with a sell rating and five have issued a buy rating to the stock. Viveve Medical currently has a consensus rating of “Buy” and an average price target of $10.40.
Viveve Medical, Inc. (VIVE) traded up $0.02 during mid-day trading on Friday, reaching $4.96. The company’s stock had a trading volume of 56,921 shares, compared to its average volume of 122,944. Viveve Medical, Inc. has a 52-week low of $3.75 and a 52-week high of $11.16. The company has a debt-to-equity ratio of 2.72, a current ratio of 3.89 and a quick ratio of 3.63.
Viveve Medical (NASDAQ:VIVE) last posted its quarterly earnings data on Wednesday, November 8th. The company reported ($0.50) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.42) by ($0.08). Viveve Medical had a negative return on equity of 275.77% and a negative net margin of 257.58%. The business had revenue of $4.07 million for the quarter, compared to analyst estimates of $4.10 million. During the same quarter in the prior year, the company earned ($0.46) earnings per share. The company’s quarterly revenue was up 120.1% on a year-over-year basis. sell-side analysts forecast that Viveve Medical, Inc. will post -2.04 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: This report was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://ledgergazette.com/2017/12/11/ing-groep-nv-has-1-70-million-stake-in-viveve-medical-inc-vive.html.
About Viveve Medical
Viveve Medical, Inc designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company’s, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories.
Receive News & Ratings for Viveve Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.